About The Second Affiliated Hospital of Kunming Medical University
The Second Affiliated Hospital of Kunming Medical University is a large general hospital in the capital of Yunnan Province, China. Established in 1952, it is among the "100 best general hospitals of China" and is the center for both human organ transplant and burn treatment in Yunnan.
There are 1,500 beds in The Second Affiliated Hospital of Kunming Medical University.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2
Janssen Research & Development, LLC
2
The Second Affiliated Hospital of Kunming Medical University
2
Zensun Sci. & Tech. Co., Ltd.
2
Air Force Military Medical University, China
1
BeiGene
1
Biohaven Pharmaceuticals, Inc.
1
Chen Xiangmei
1
Children's Hospital of Chongqing Medical University
1
Chinese Academy of Medical Sciences, Fuwai Hospital
1
Chinese PLA General Hospital
1
Clinical Trials at The Second Affiliated Hospital of Kunming Medical University
During the past decade, The Second Affiliated Hospital of Kunming Medical University conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
2012-02-01
2017-08-01
Terminated
679
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
2011-10-01
2013-10-01
Unknown status
15
In Vitro Maturation Induction of Oocytes From a Woman With Syndrome of Repeated Oocyte Maturation Failure in Vitro
2012-03-01
2012-04-01
Completed
1
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
2014-01-01
Completed
30,400
Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy
2014-09-01
2017-12-01
Unknown status
1,600
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
2014-09-01
2016-12-01
Unknown status
1,600
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Second Affiliated Hospital of Kunming Medical University" #1 sponsor was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials
sponsored, "The Second Affiliated Hospital of Kunming Medical University" with 2 trials sponsored, "Zensun Sci. & Tech. Co., Ltd." with 2 trials sponsored and "Air Force Military Medical University, China"
with 2 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Kunming Medical University"
#1 collaborator was "The Second Affiliated Hospital of Kunming Medical University" with 4 trials as a collaborator, "The Second Hospital of Hebei Medical University" with 3 trials as a collaborator, "Anhui Provincial Children's Hospital" with 2 trials as a collaborator, "First Affiliated Hospital of Kunming Medical University" with 2 trials as a collaborator and "Henan Provincial People's Hospital" with 2 trials as a collaborator. Other collaborators include 128 different institutions and companies that were
collaborators in the rest 135 trials.
Clinical Trials Conditions at The Second Affiliated Hospital of Kunming Medical University
According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Kunming Medical University" are
"Acute Migraine" (2 trials), "Chronic Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Adenocarcinoma of the Lung" (1 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Kunming Medical University" in a lesser frequency.
Clinical Trials Intervention Types at The Second Affiliated Hospital of Kunming Medical University
Most popular intervention types in "The Second Affiliated Hospital of Kunming Medical University" are "Drug" (22 trials), "Biological" (3 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "rhNRG-1" (2 trials), "Abelmoschus manihot" (1 trials), "Abelmoschus manihot (AM)" (1 trials) and "Abiraterone acetate tablets" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Second Affiliated Hospital of Kunming Medical University
The vast majority of trials in "The Second Affiliated Hospital of Kunming Medical University" are
25 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.
Clinical Trials Status at The Second Affiliated Hospital of Kunming Medical University
Currently, there are NaN active trials in "The Second Affiliated Hospital of Kunming Medical University".
2 are not yet recruiting,
11 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in The Second Affiliated Hospital of Kunming Medical University,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Second Affiliated Hospital of Kunming Medical University, 6 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 2 trials that are defined as “Not Applicable".